Esophageal Adenocarcinoma Methods and Protocols

(sharon) #1

246


drying the beads. Under conditions of low relative humidity,
the beads air-dry rapidly. Do not overdry.


  1. The enriched ion sphere particles can be stored at 2–8 °C for
    up to 3 days.

  2. When performing two sequencing runs from the same initial-
    ization, the second run must start within 24 h after start of
    initialization.


References



  1. Mardis ER (2013) Next-generation sequencing
    platforms. Annu Rev Anal Chem 6:287–303

  2. Pillai S, Gopalan V, Lo CY et al (2016) Silent
    genetic alterations identified by targeted next-
    generation sequencing in pheochromocy-
    toma/paraganglioma: a clinicopathological
    correlations. Exp Mol Pathol 102:41–46

  3. Zheng H, Wang Y, Tang C et al (2016) TP53,
    PIK3CA, FBXW7 and KRAS mutations in
    esophageal cancer identified by targeted sequenc-
    ing. Cancer Genomics Proteomics 13:231–238

  4. Weaver JM, Ross-Innes CS, Fitzgerald RC
    (2014) The ‘-omics’ revolution and esopha-
    geal adenocarcinoma. Nat Rev Gastroenterol
    Hepatol 11:19–27

  5. van El CG, Cornel MC, Borry P et al (2013)
    Whole-genome sequencing in health care:
    recommendations of the European Society of
    Human Genetics. Eur J Hum Genet 21:1–5

  6. Ding L, Wendl MC, Koboldt DC et al (2010)
    Analysis of next-generation genomic data in
    cancer: accomplishments and challenges. Hum
    Mol Genet 19:188–196

  7. Ross-Innes CS, Becq J, Warren A et al (2015)
    Whole-genome sequencing provides new
    insights into the clonal architecture of Barrett’s
    esophagus and esophageal adenocarcinoma.
    Nat Genet 47:1038–1046

  8. Dulak AM, Stojanov P, Peng S et al (2013)
    Exome and whole-genome sequencing of
    esophageal adenocarcinoma identifies recur-
    rent driver events and mutational complexity.
    Nat Genet 45:478–486

  9. Streppel MM, Lata S, DelaBastide M et al
    (2014) Next-generation sequencing of endo-
    scopic biopsies identifies ARID1A as a tumor-
    suppressor gene in Barrett’s esophagus.
    Oncogene 33:347–357

  10. Bainbridge MN, Wang M, Burgess DL et al
    (2010) Whole exome capture in solution with
    3 Gbp of data. Genome Biol 11:R62
    11. Meyerson M, Gabriel S, Getz G (2010)
    Advances in understanding cancer genomes
    through second-generation sequencing. Nat
    Rev Genet 11:685–696
    12. Rabbani B, Tekin M, Mahdieh N (2014) The
    promise of whole-exome sequencing in medi-
    cal genetics. J Hum Genet 59:5–15
    13. Agrawal N, Jiao Y, Bettegowda C, Hutfless
    SM et al (2012) Comparative genomic
    analysis of esophageal adenocarcinoma and
    squamous cell carcinoma. Cancer Discov
    2:899–905
    14. Wang X, Li X, Cheng Y et al (2015) Copy
    number alterations detected by whole-exome
    and whole-genome sequencing of esophageal
    adenocarcinoma. Hum Genomics 9:22
    15. Findlay JM, Castro-Giner F, Makino S et al
    (2016) Differential clonal evolution in esopha-
    geal cancers in response to neo-adjuvant che-
    motherapy. Nat Commun 7:11111
    16. Parla JS, Iossifov I, Grabill I et al (2011)
    A comparative analysis of exome capture.
    Genome Biol 12:97
    17. Welander J, Andreasson A, Juhlin CC et al
    (2014) Rare germline mutations identified
    by targeted next-generation sequencing of
    susceptibility genes in pheochromocytoma
    and paraganglioma. J Clin Endocrinol Metab
    99:1352–1360
    18. Quail MA, Smith M, Coupland P et al (2012)
    A tale of three next generation sequencing
    platforms: comparison of Ion Torrent, Pacific
    Biosciences and Illumina MiSeq sequencers.
    BMC Genomics 13:341
    19. Margulies M, Egholm M, Altman WE et al
    (2005) Genome sequencing in microfabri-
    cated high-density picolitre reactors. Nature
    43:376–380
    20. Moorthie S, Mattocks CJ, Wright CF (2011)
    Review of massively parallel DNA sequencing
    technologies. HUGO J 5:1–12


Suja Pillai et al.
Free download pdf